Thalidomide alone or in combination with other agents for the treatment of myelodysplastic syndromes (MDS)

被引：2
|
作者：
Candoni, A.
Raza, A.
Galili, N.
Simeone, E.
Buttignol, S.
Silvestri, F.
Fanin, R.
机构：
[1] Univ Hosp, Div Hematol Bone Marrow Transplantat, Udine, Italy
[2] Univ Massachusetts, Med Ctr, Amherst, MA 01003 USA
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70214-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [21] Myelodysplastic syndromes (MDS)
    Reinhard Stauder
    memo - Magazine of European Medical Oncology, 2009, 2 (2) : 108 - 109
  • [22] Cytogenetic and clonal profile of myelodysplastic syndromes (MDS) patients treated with thalidomide.
    Alvi, S
    Shaikh, M
    Anthwal, S
    Shaher, A
    Tamoseviciene, D
    Novick, A
    Reddy, P
    Allampallam, K
    Hsu, WT
    Galili, N
    Borok, RZ
    Raza, A
    BLOOD, 2001, 98 (11) : 352A - 352A
  • [23] Myelodysplastic syndromes (MDS)
    Stauder, R.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (02) : 108 - 109
  • [24] Myelodysplastic syndromes (MDS)
    Germing, U.
    Kuendgen, A.
    Haas, R.
    Gattermann, N.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (05) : 183 - 185
  • [25] Myelodysplastic syndromes (MDS)
    Burgstaller S.
    memo - Magazine of European Medical Oncology, 2014, 7 (3) : 134 - 137
  • [26] BESTATIN TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) AND THE EFFECTS OF BESTATIN ON HEMATOPOIESIS IN MDS
    UZUKA, Y
    SAITO, Y
    ACTA ONCOLOGICA, 1990, 29 (06) : 803 - 807
  • [27] Guideline for the treatment of myelodysplastic syndromes (MDS) in South Africa
    Louw, V. J.
    Bassa, F.
    Chan, S. W.
    Dreosti, L.
    du Toit, M.
    Ferreira, M.
    Gartrell, K.
    Gunther, K.
    Jogessar, V.
    Littleton, N.
    Mahlangu, J.
    McDonald, A.
    Patel, M.
    Pool, R.
    Ruff, P.
    Schmidt, A.
    Sissolak, G.
    Swart, A.
    Verburgh, E.
    Webb, M. J.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2011, 101 (12): : 900 - 906
  • [28] Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS)
    List, AF
    SEMINARS IN ONCOLOGY, 2005, 32 (04) : S31 - S35
  • [29] Hypomethylating agents for the treatment of myelodysplastic syndromes
    Itzykson, Raphael
    Fenaux, Pierre
    BULLETIN DU CANCER, 2011, 98 (08) : 927 - 934
  • [30] Combination of thalidomide and etanercept (Tumor necrosis factor receptor OR TNFR) effective in improving the cytopenias of some patients with myelodysplastic syndromes (MDS).
    Raza, A
    Lisak, LA
    Tahir, S
    Billmeier, JM
    Willmann, HS
    Alvi, MI
    Bellak, DJ
    Gezer, S
    Venugopal, P
    BLOOD, 2002, 100 (11) : 340B - 340B
12345